» Articles » PMID: 34172718

Clinical Efficacy of Nanohydroxyapatite-containing Toothpaste at Relieving Dentin Hypersensitivity: an 8 Weeks Randomized Control Trial

Overview
Journal BDJ Open
Specialty Dentistry
Date 2021 Jun 26
PMID 34172718
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to investigate and compare the effectiveness of several toothpastes containing nanohydroxyapatite (nano-HAP) to relieve dentin hypersensitivity (DHS) with that of a commercial desensitizing dentifrice containing calcium sodium phosphosilicate (CSPS).

Materials And Methods: In this double-blind, randomized, parallel-group clinical trial, patients diagnosed with DHS and qualified to participate were randomized into four groups: toothpaste containing 10% nano-HAP (10%nano-HAP), 15% nano-HAP (15%nano-HAP), 10% nano-HAP supplemented with potassium nitrate (KNO) (10%nano-HAPKN), or CSPS. Subjects' baseline and post-treatment sensitivities were assessed using visual analog scale (VAS) after the application of ice-cold and air stimuli. Subjects used their assigned toothpaste for routine toothbrushing twice daily. Post-treatment sensitivity was assessed every 2 or 8 weeks. Mean change in VAS (mm) from baseline at each time point were compared using random-intercept, mixed-model analysis and Duncan test (P < 0.05).

Results: With either air or cold stimulus, VAS indicated a significant (P < 0.001) reduction from baseline DHS at each time point with all test toothpastes. Among the nano-HAP toothpastes, 15%nano-HAP and 10%nano-HAPKN were consistent in DHS reduction with both stimuli. With either stimuli, the CSPS did not significantly differ from 15%nano-HAP and 10%nano-HAPKN at any time point.

Conclusions: Toothpaste containing nano-HAP (10 or 15%) alone or supplemented with KNO was as effective as CSPS for relief of DHS symptoms when used at least twice daily.

Citing Articles

Comparative Study of Anti-COVID Mouthwash and Remineralization Agents on Dentinal Tubular Occlusion: An Study.

Soleimanyfar M, Tabatabaei S J Int Soc Prev Community Dent. 2025; 14(6):453-460.

PMID: 39867632 PMC: 11756714. DOI: 10.4103/jispcd.jispcd_80_24.


Advancements in nanohydroxyapatite: synthesis, biomedical applications and composite developments.

Zhao R, Meng X, Pan Z, Li Y, Qian H, Zhu X Regen Biomater. 2025; 12:rbae129.

PMID: 39776858 PMC: 11703556. DOI: 10.1093/rb/rbae129.


Nanotechnology in toothpaste: Fundamentals, trends, and safety.

Abedi M, Ghasemi Y, Nemati M Heliyon. 2024; 10(3):e24949.

PMID: 38317872 PMC: 10838805. DOI: 10.1016/j.heliyon.2024.e24949.


Nanohydroxyapatite in dentistry: A comprehensive review.

Pushpalatha C, Gayathri V, Sowmya S, Augustine D, Alamoudi A, Zidane B Saudi Dent J. 2023; 35(6):741-752.

PMID: 37817794 PMC: 10562112. DOI: 10.1016/j.sdentj.2023.05.018.


Improving Oral Health with Fluoride-Free Calcium-Phosphate-Based Biomimetic Toothpastes: An Update of the Clinical Evidence.

Limeback H, Enax J, Meyer F Biomimetics (Basel). 2023; 8(4).

PMID: 37622936 PMC: 10452078. DOI: 10.3390/biomimetics8040331.


References
1.
Irwin C, McCusker P . Prevalence of dentine hypersensitivity in a general dental population. J Ir Dent Assoc. 1997; 43(1):7-9. View

2.
Schmidlin P, Sahrmann P . Current management of dentin hypersensitivity. Clin Oral Investig. 2013; 17 Suppl 1:S55-9. PMC: 3585982. DOI: 10.1007/s00784-012-0912-0. View

3.
Rees J, Addy M . A cross-sectional study of dentine hypersensitivity. J Clin Periodontol. 2002; 29(11):997-1003. DOI: 10.1034/j.1600-051x.2002.291104.x. View

4.
Luong M, Huang L, Chan D, Sadr A . In Vitro Study on the Effect of a New Bioactive Desensitizer on Dentin Tubule Sealing and Bonding. J Funct Biomater. 2020; 11(2). PMC: 7353572. DOI: 10.3390/jfb11020038. View

5.
Poulsen S, Errboe M, Hovgaard O, Worthington H . Potassium nitrate toothpaste for dentine hypersensitivity. Cochrane Database Syst Rev. 2001; (2):CD001476. DOI: 10.1002/14651858.CD001476. View